News from american diabetes association A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jan 07, 2020, 14:16 ET American Diabetes Association® Welcomes 2020 Principal Officers and New Members to National Board of Directors

The American Diabetes Association (ADA) welcomes the 2020 Principal Officers and Board of Directors. The 18-member board is comprised of...


Dec 20, 2019, 14:00 ET Cardiovascular Disease, Technology and Personalized Care Highlighted in ADA's 2020 Standards of Medical Care in Diabetes

A strong recurring message of individualizing patient care is echoed throughout the American Diabetes Association's Standards of Medical Care in...


Nov 15, 2019, 08:31 ET Silicon Valley Rocks! Returns to the Stage on December 3rd in Support of the American Diabetes Association®

Silicon Valley Rocks!, the first musical fundraiser to feature bands with members from the tech community, will be taking place on Tuesday, December...


Nov 14, 2019, 08:03 ET American Diabetes Association® and VSP® Vision Care Collaborate on Public Health Initiative to Save Sight in People with Diabetes

The American Diabetes Association (ADA) today announced a new collaboration with VSP® Vision Care, a VSP Global® company which serves nearly 90...


Nov 07, 2019, 18:44 ET American Diabetes Association® Celebrates Cockpit Doors Opening for People with Diabetes with Publication of New Federal Aviation Administration Protocol

Today, the American Diabetes Association (ADA) applauds the Federal Aviation Administration (FAA) for announcing a protocol for pilots with...


Nov 01, 2019, 10:30 ET American Diabetes Association® Launches Count Me In Campaign to Change the Numbers on the Diabetes Epidemic: Can We Count You In?

This November, the American Diabetes Association (ADA) is highlighting the numbers that matter most when it comes to those living with, at risk and...


Oct 30, 2019, 11:56 ET The American Diabetes Association® Applauds the Insulin Price Reduction Act, Introduced Yesterday by the House Diabetes Caucus

The American Diabetes Association (ADA) strongly supports the introduction of the Insulin Price Reduction Act in the United States House of...


Oct 28, 2019, 07:35 ET American Diabetes Association® Answers the Question "What Can I Eat?"

In conjunction with a session at the Academy of Nutrition and Dietetics Food & Nutrition Conference & Expo (FNCE), the American Diabetes Association...


Sep 25, 2019, 18:36 ET American Diabetes Association® Launches New Communications & Engagement Platform to Empower Advocates

The American Diabetes Association (ADA) has created a free Communications & Engagement Platform to demystify the political rhetoric of drug pricing...


Jul 31, 2019, 15:15 ET Updates to the 2019 Standards of Medical Care in Diabetes Issued Today by the American Diabetes Association®

The American Diabetes Association® (ADA) issued important updates to the 2019 Standards of Medical Care in Diabetes (Standards of Care) today, in...


Jul 22, 2019, 17:07 ET The American Diabetes Association® Applauds the Insulin Price Reduction Act, Introduced Today by the Senate Diabetes Caucus

The American Diabetes Association (ADA) strongly supports the introduction of the Insulin Price Reduction Act in the United States Senate. The ADA...


Jun 17, 2019, 16:00 ET American Diabetes Association® Celebrates 70 Years of Fun, Educational Camps for Children

For 70 years, the American Diabetes Association (ADA) has hosted summer camps for children and teens with type 1 diabetes. In 2019 nearly 7,000...


Jun 11, 2019, 14:45 ET Oral Semaglutide Reduces Occurrence of Major Cardiac Events in People with Type 2 Diabetes With High Cardiovascular Risk

Results of the PIONEER 6 trial indicate oral semaglutide is safe for patients with type 2 diabetes (T2D) at high cardiovascular (CV) risk, according...


Jun 11, 2019, 12:54 ET Safety of Linagliptin for Adults with Type 2 Diabetes Who Have High Risk of Cardiovascular and/or Renal Disease Examined in CARMELINA

Linagliptin, when added to usual diabetes care in people with type 2 diabetes (T2D) with increased risk of cardiovascular (CV) and/or renal disease,...


Jun 11, 2019, 12:30 ET Canagliflozin Shown to Improve Cardiovascular and Renal Outcomes in People with Type 2 Diabetes and Kidney Disease

For people with type 2 diabetes (T2D) and chronic kidney disease (CKD), canagliflozin, an oral, sodium-glucose co-transporter-2 (SGLT2) inhibitor,...


Jun 10, 2019, 21:30 ET Linagliptin and Glimepiride Have Comparable Cardiovascular Safety Effects in Type 2 Diabetes at High Cardiovascular Risk

The diabetes medications glimepiride and linagliptin had similar impacts on cardiovascular morbidity and mortality for a median period of 6.3 years,...


Jun 10, 2019, 14:20 ET Dulaglutide is Safe and Effective for People with Type 2 Diabetes and Moderate to Severe Chronic Kidney Disease

In an analysis of the AWARD-7 study, people with type 2 diabetes (T2D) and moderate-to-severe chronic kidney disease (CKD) who took 1.5 mg of...


Jun 10, 2019, 13:00 ET Access to Continuous Glucose Monitors in Pediatric Diabetes Populations Improves Glycemic Control, Reduces Hypoglycemia and Improves Satisfaction with Diabetes Care and Technology Use

Diabetes requires management 24 hours a day, seven days a week, 365 days of the year and presents numerous daily challenges, particularly for...


Jun 09, 2019, 22:04 ET Dapagliflozin Reduces Progression of Kidney Disease and Renal Death in People with Type 2 Diabetes

The first sub-analysis of renal data from the Dapagliflozin Effect on Cardiovascular Events Thrombolysis In Myocardial Infarction (DECLARE-TIMI 58)...


Jun 09, 2019, 21:30 ET Type 1 Diabetes May Affect Brain Development, Beginning in Early Childhood

Children with early-onset type 1 diabetes (T1D) and poor glycemic control have slower growth of areas in the brain associated with mild cognitive...


Jun 09, 2019, 21:30 ET Dulaglutide Reduces Cardiovascular Disease in People with Type 2 Diabetes

The Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND) trial has found dulaglutide, an injectable, glucagon-like peptide-1 ...


Jun 09, 2019, 16:30 ET Two RISE Clinical Trials in Youth and Adults with Impaired Glucose Tolerance or Newly Diagnosed Type 2 Diabetes Reveal Surprising Differences in Beta-Cell (β-cell) Function During and After Treatment

In a study measuring Beta-cell (β-cell) function in adults with impaired glucose tolerance (IGT) or newly diagnosed type 2 diabetes (T2D),...


Jun 09, 2019, 16:00 ET Consistent Use of Diabetes Technology Across Multiple Environments Benefits Youth with Diabetes

In recent years, diabetes technology has evolved at a rapid pace, and the use of insulin pumps and continuous glucose monitoring (CGM) systems has...


Jun 09, 2019, 13:00 ET Delayed Onset of Type 2 Diabetes by Six Years or More Significantly Reduces Risk of Cardiovascular Disease and Microvascular Disease

People with impaired glucose tolerance (IGT) may significantly lower their risk of cardiovascular disease (CVD) and microvascular disease by delaying ...


Jun 09, 2019, 13:00 ET Teplizumab Delays Clinical Diagnosis of Type 1 Diabetes an Average of Two Years, According to Study Presented at ADA's Scientific Sessions

The Teplizumab Prevention Trial has given validity to the concept that immune therapy can delay the diagnosis of type 1 diabetes (T1D), according to...